SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-23-004130
Filing Date
2023-05-31
Accepted
2023-05-31 16:56:08
Documents
11
Period of Report
2023-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F betrf_20f.htm 20-F 441935
2 CERTIFICATION betrf_ex121.htm EX-12.1 12347
3 CERTIFICATION betrf_ex122.htm EX-12.2 13019
4 CERTIFICATION betrf_ex131.htm EX-13.1 3973
5 CERTIFICATION betrf_ex132.htm EX-13.2 3957
6 CONSOLIDATED FINANCIAL STATEMENTS betrf_ex991.htm EX-99.1 1259530
7 MANAGEMENT'S DISCUSSION AND ANALYSIS betrf_ex992.htm EX-99.2 216409
8 betrf_ex991img3.jpg GRAPHIC 2244
9 betrf_ex991img2.jpg GRAPHIC 1531
10 betrf_ex991img1.jpg GRAPHIC 3102
11 betrf_ex992img1.jpg GRAPHIC 4291
  Complete submission text file 0001477932-23-004130.txt   1968267
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 438-884-8841
BetterLife Pharma Inc. (Filer) CIK: 0001464165 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
Type: 20-F | Act: 34 | File No.: 333-161157 | Film No.: 23981794
SIC: 2834 Pharmaceutical Preparations